Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip Administered Intravenously to Severe Haemophilia A Patients With and Without Inhibitors to FVIII

NCT04592692 is registered in ClinicalTrials.gov with Ascension Healthcare Development Limited as lead sponsor.

NCT NCT04592692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04592692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip Administered Intravenously to Severe Haemophilia A Patients With and Without Inhibitors to FVIII
Lead sponsor
Ascension Healthcare Development Limited
Phase
Phase 2
Overall status
Unknown status
Start date
December 23, 2019
Completion date
May 31, 2022
Enrollment
20 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a with inhibitor